| Autor: |
Satyakam Mohapatra, Mihir Ranjan Nayak |
| Jazyk: |
angličtina |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Indian Journal of Psychological Medicine, Vol 39, Iss 3, Pp 350-351 (2017) |
| Druh dokumentu: |
article |
| ISSN: |
0253-7176 |
| DOI: |
10.4103/0253-7176.207314 |
| Popis: |
Cabergoline, a dopamine agonist agent, is commonly used in the treatment of hyperprolactinemia, Parkinson's disease, restless leg syndrome, and antipsychotic-induced prolactin elevation. It is generally well tolerated as compared to other dopamine agonist agents due to its more selective D2 receptor agonistic effect. We present a case of a 25-year-old female who developed manic episode, following the use of cabergoline for treatment of pituitary microadenoma. We suggest that physicians should carefully screen patients before initiating cabergoline therapy and at-risk patients may benefit from more frequent monitoring and cessation of therapy at the earliest safe juncture. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
